DEPICTION OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) PREVALENCE IN PRIMARY CARE IN GREECE
Author(s)
Alexandra Christodoulopoulou, MSc, Health Economics Manager1, George Papatheodoridis, MD, Consultant2, Maria Pangali, MSc, Health Economics Associate1, Maria Papageorgiou, MSc, MBA, Health Economics Associate11AstraZeneca SA, Athens, Greece; 2 Ippokration General Hospital, Athens, Greece
OBJECTIVES: GERD is a frequent condition among the general population, which is not often properly diagnosed or treated. The study aimed to depict the prevalence of GERD within a primary care setting, assess symptoms severity and frequency in GERD patients, and to examine the association between GERD and aspirin/NSAIDs use. METHODS: A total of 2878 individuals (M/F: 1411/1467, mean age 55, 19±14,5 years, BMI 26, 7±3, 9 Kg/m2) visiting 300 Primary Care Practitioners (PCP) between November-December 2005 were included. Demographic and medical history data including aspirin/NSAID use, the presence and severity-frequency of GERD and dyspepsia symptoms were recorded, using a structured questionnaire. GERD (heartburn, regurgitation) and dyspepsia (epigastric pain, early satiety, postprandial fullness) diagnoses were based on widely accepted epidemiological criteria.RESULTS:The main reasons for patients visiting PCPs were prescription renewal (32.9%) and consultation for upper GI symptoms (28.6%). GERD symptoms were reported by 57.4% and dyspepsia by 67.6% of the 2878 patients during the last week before visiting their PCP. Among patients with upper GI symptoms, GERD or dyspepsia was reported almost equally as predominant symptom by 34.2% and 35.6% of patients respectively, while another 4.9% reported symptoms of both diagnoses as predominant. GERD symptoms were mild in 33%, moderate in 40% and severe in 12% of the patients, while present for 2 days/week in 29%, 3-5 days/week in 39% and 6-7 days/week in 17% of cases. GERD and/or dyspepsia symptoms were reported by 81.7% of users and as opposed to 62.5% of non-aspirin/NSAID users during the last two weeks before visiting their PCP (P=0.043). CONCLUSIONS:In patients who use primary care health resources, GERD symptoms are highly prevalent (57%), being present for at least 2 days/week in 85% and of moderate/severe intensity in more than 50% of symptomatic patients. Aspirin/NSAID use substantially increases prevalence of GERD and dyspepsia symptoms.
Conference/Value in Health Info
2006-10, ISPOR Europe 2006, Copenhagen, Denmark
Value in Health, Vol. 9, No.6 (November/December 2006)
Code
PGI17
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Gastrointestinal Disorders